Biotech · Private company · Charleston, SC, US

Fibrotherapeutics, Inc.

Track this companyFree. Adds Fibrotherapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

A Novel Water-Soluble, Orally-Active Peptide Therapeutic for Interstitial Lung Disease Derived from the Caveolin-1 Scaffolding DomainFiscal year 2026 · $920.6KNIH RePORTER 1R44HL186828-01 · fetched Nov 12, 2026
Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development: Phase IIFiscal year 2026 · $1.9MNIH RePORTER 2R42HL167327-02 · fetched Nov 12, 2026
Novel Therapeutic for Kidney Failure: A Modified, Water-Soluble Orally-Active Caveolin-1 Scaffolding Domain Peptide with Improved Characteristics for Drug DevelopmentFiscal year 2024 · $337.7KNIH RePORTER 1R41DK141315-01 · fetched Nov 12, 2026
Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug DevelopmentFiscal year 2024 · $6.5KNIH RePORTER 3R41HL167327-01S1 · fetched Nov 12, 2026